Background To date, several clinical laboratory parameters associated with Coronavirus
disease 2019 (COVID-19) severity have been reported. However, these parameters have not …

Background Targeting short-term improvements in multicomponent risk scores for mortality
in patients with pulmonary arterial hypertension (PAH) could result in improved long-term …

Rationale: The 6-minute-walk distance (6MWD) is an important clinical and research metric
in pulmonary arterial hypertension (PAH); however, there is no consensus about what …

Background Birth asphyxia is a consistent key contributor to neonatal morbidity and mortality,
notably in sub-Saharan Africa. The APGAR score, though a globally used diagnostic tool …

Background Hepatopulmonary syndrome affects 10–30% of patients with cirrhosis and portal
hypertension. We evaluated the serum angiogenic profile of hepatopulmonary syndrome …

Rationale: Sex-based differences in pulmonary arterial hypertension (PAH) are known, but
the contribution to disease measures is understudied. Objectives: We examined whether sex …

Introduction Premenstrual syndrome (PMS) has the potential to affect the quality of life
adversely. Published guidelines recommend the use of exercise as part of the first-line …

Background Obesity is increasingly prevalent in pulmonary arterial hypertension (PAH) but
is associated with improved survival, creating an “obesity paradox” in PAH. It is unknown if …

Background It is currently unknown if disease severity modifies response to therapy in
pulmonary arterial hypertension (PAH). We aimed to explore if disease severity, as defined by …

Background Chronic kidney disease (CKD) poses a substantial health burden in sub-Saharan
Africa, with risk factors ranging from communicable to non-communicable diseases. …